| Name | N-Trityl Candesartan |
|---|---|
| Synonyms |
2-Ethoxy-1-{[2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid
2-Ethoxy-1-{[2'-(1-trityl-1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-benzimidazole-7-carboxylic acid 1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]- Trityl candesartan 2-ETHOXY-1-[[(2-(1-TRIPHENYLMETHYL-1H-TETRAZOL-5-YL)BIPHENYL)METHYL] BENZIMIDAZOLE-7-CARBOXYLIC ACID Candesartan Cilexetil Impurity 14 |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 908.6±75.0 °C at 760 mmHg |
| Melting Point | 163-165ºC |
| Molecular Formula | C43H34N6O3 |
| Molecular Weight | 682.768 |
| Flash Point | 503.3±37.1 °C |
| Exact Mass | 682.269226 |
| PSA | 107.95000 |
| LogP | 10.15 |
| Vapour Pressure | 0.0±0.3 mmHg at 25°C |
| Index of Refraction | 1.678 |
| Storage condition | Refrigerator |
| Hazard Codes | Xi |
|---|---|
| HS Code | 2933990090 |
|
~88%
139481-72-4 |
| Literature: Alembic Limited Patent: US2010/210852 A1, 2010 ; Location in patent: Page/Page column 5 ; |
|
~%
139481-72-4 |
| Literature: US6177587 B1, ; |
|
~%
139481-72-4 |
| Literature: WO2011/145100 A1, ; |
|
~%
139481-72-4 |
| Literature: WO2011/145100 A1, ; |
|
~%
139481-72-4 |
| Literature: WO2011/145100 A1, ; |
|
~%
139481-72-4 |
| Literature: WO2011/145100 A1, ; |
|
~%
139481-72-4 |
| Literature: WO2011/145100 A1, ; |
|
~%
139481-72-4 |
| Literature: WO2011/145100 A1, ; |
|
~%
139481-72-4 |
| Literature: WO2011/145100 A1, ; |
| Precursor 10 | |
|---|---|
| DownStream 2 | |
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |